The iconic rise of Viagra presented a significant chance for investors , but its exclusivity has lapsed , creating a challenging landscape. Off-brand versions have flooded click here the arena, diminishing revenues and putting pressure on profit margins . While major healthcare companies continue a foothold in this area, the potential remains uncle